The actions to be funded under this topic are expected to achieve the following:
a. contribute to one or more of IHI JU's expected impacts linked to Specific Objective 1 as set out in the IHI JU SRIA, i.e.:
- patients benefit from preventive treatment or early disease intervention before onset of symptoms;
- prevention and early diagnosis of disease combined with better understanding of the mechanisms involved, leading to the development of more cost-effective strategies;
- patients benefitting from improved healthcare through regular monitoring of critical parameters using validated tools;
- development of new vaccine strategies targeted to specific sub-populations;
- increased preparedness of EU healthcare systems for disease outbreaks.
b. contribute to strengthening the competitiveness of the EU's health industry, via increased economic activity in the development of health technologies, in particular, integrated health solutions, thus fostering European technological leadership and the digital transformation of our societies.
The actions are expected to contribute to EU programmes, initiatives and policies such as the European Green Deal, Europe's Beating Cancer Plan, the EU Mission on Cancer, the European Virtual Human Twins Initiative, the European Health Emergency Preparedness and Response Authority (HERA), the European Commission's proposal for the European Health Data Space (EHDS), and the EU Artificial Intelligence Act1, where relevant.
1
...
